BLEEDING
Clinical trials for BLEEDING explained in plain language.
Never miss a new study
Get alerted when new BLEEDING trials appear
Sign up with your email to follow new studies for BLEEDING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a single pill replace two after heart implant? major trial seeks safer stroke prevention
Disease control OngoingThis study tests whether people with atrial fibrillation who receive a WATCHMAN FLX Pro device can safely take just one blood thinner or aspirin instead of the usual two-drug plan. About 1,857 participants are being followed for six months to compare rates of death, stroke, major…
Matched conditions: BLEEDING
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a tiny implant replace daily blood thinners for AFib patients?
Disease control OngoingThis large study is testing whether a device called WATCHMAN FLX, which closes off a small pouch in the heart, can be a safe and effective alternative to daily blood thinners (NOACs) for preventing strokes in people with non-valvular atrial fibrillation. The trial involves 3,000 …
Matched conditions: BLEEDING
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New Blood-Clot monitor could cut transfusions in heart surgery
Disease control OngoingThis study tests whether a bedside device called Quantra can help doctors decide when to give blood transfusions during complex heart surgery. The device measures how well a patient's blood clots in real time. Researchers hope this will reduce the number of blood products (like r…
Matched conditions: BLEEDING
Phase: NA • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Which blood thinner works best after heart device implant? new trial aims to find out
Disease control OngoingThis study compares two approaches—short-term anticoagulation (stronger blood thinners) versus antiplatelet therapy (milder blood thinners)—to prevent clots on a device placed in the heart's left atrial appendage. The trial involves 510 adults who have had this procedure. The goa…
Matched conditions: BLEEDING
Phase: PHASE4 • Sponsor: Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Bleeding breakthrough? study tests tranexamic acid in bariatric surgery
Disease control OngoingThis study looks at whether giving tranexamic acid (a drug that helps blood clot) during weight-loss surgery can reduce dangerous bleeding. About 1000 adults having bariatric surgery will be split into two groups: one gets the drug, the other gets standard care. The goal is to se…
Matched conditions: BLEEDING
Phase: NA • Sponsor: Santa Maria Hospital - GVM Care & Research • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Heart device vs. pills: which better prevents strokes in AFib patients?
Disease control OngoingThis study tests if a device that closes a small pouch in the heart (left atrial appendage) is safer and more effective than long-term blood thinners for preventing strokes in people with atrial fibrillation. About 2,650 participants with AFib and high stroke risk are randomly as…
Matched conditions: BLEEDING
Phase: NA • Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New study tracks amulet Device's Real-World success in preventing strokes
Disease control OngoingThis study observes over 600 people with atrial fibrillation who received the Amulet device to close a part of the heart called the left atrial appendage. The goal is to see how well the device prevents strokes and bleeding in everyday medical practice. Participants are followed …
Matched conditions: BLEEDING
Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Can a simple drug make kidney biopsies safer for transplant patients?
Disease control ENROLLING_BY_INVITATIONThis study tests whether desmopressin, a drug that helps blood clot, can prevent bleeding during kidney biopsies in transplant patients. Researchers will give 96 high-risk patients either desmopressin or a placebo before the procedure and compare bleeding rates. The goal is to se…
Matched conditions: BLEEDING
Phase: PHASE4 • Sponsor: Hospital de Clinicas de Porto Alegre • Aim: Disease control
Last updated Jun 26, 2026 16:20 UTC
-
Storytelling may boost blood thinner use in black heart patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests whether watching storytelling videos can help African American and Black patients with atrial fibrillation (an irregular heartbeat) start and continue taking blood thinners to prevent strokes. About 80 adults who are not currently on blood thinners but have a hig…
Matched conditions: BLEEDING
Phase: NA • Sponsor: University of Massachusetts, Worcester • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Blood thinner safety in artery surgery under review
Knowledge-focused OngoingThis study reviews the medical records of 500 people who had surgery on major arteries (not heart surgery). It aims to see if taking blood thinners (antiplatelet or anticoagulant drugs) around the time of surgery affects the chance of bleeding or blood clots. The researchers comp…
Matched conditions: BLEEDING
Sponsor: Petrovsky National Research Centre of Surgery • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Study to improve bleeding care in blood thinner users withdrawn
Knowledge-focused TerminatedThis study was designed to see if a checklist could help doctors better manage major bleeding in patients taking blood thinners. It planned to include 168 adults in Brazil who were on long-term blood thinners and had a major bleed. The study was withdrawn before any participants …
Matched conditions: BLEEDING
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Aspirin's hidden legacy: 19,000 seniors tracked for delayed effects
Knowledge-focused OngoingThis study follows over 19,000 older adults who previously took aspirin in a clinical trial. Researchers are monitoring them for delayed effects on cancer, dementia, disability, and death. The goal is to see if aspirin has any long-term benefits or risks years after stopping the …
Matched conditions: BLEEDING
Sponsor: Anne Murray • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC